|
|||||
 |
Thimerosal Content in Some US Licensed Vaccines
the information in the table was updated May 2, 2012
|
Vaccine |
Brand Name |
Manufacturer |
Thimerosal Concentration |
Mercury
Mcg/0.5 mL |
|||
|
Anthrax
|
BioThrax |
BioPort Corp |
0 |
0 |
|||
|
DTaP
|
Daptacel |
sanofi pasteur |
0 |
0 |
|||
|
Infanrix |
GlaxoSmithKline |
0 |
0 |
||||
|
Tripedia |
sanofi pasteur |
||||||
|
DTaP+HepB+IPV
|
Pediarix |
GlaxoSmithKline |
0 |
0 |
|||
|
DTaP+Hib
|
TriHIBit (ActHIB+Tripedia) |
sanofi pasteur |
* |
* |
|||
|
DTaP+IPV
|
Kinrix |
GlaxoSmithKline |
0 |
0 |
|||
|
DTaP+IPV+Hib
|
Pentacel |
sanofi pasteur |
0 |
0 |
|||
|
DT
|
Diphtheria & Tetanus Toxoids Adsorbed USP |
sanofi pasteur |
* |
* |
|||
|
Td
|
Decavac |
sanofi pasteur |
* |
* |
|||
|
Tetanus and Diphtheria Toxoids Adsorbed |
Mass Biolocial Labs |
* |
* |
||||
|
Tdap
|
Adacel |
sanofi pasteur |
0 |
0 |
|||
|
Boostrix |
GlaxoSmithKline |
0 |
0 |
||||
|
Tetanus Toxoid
|
Generic |
sanofi pasteur |
.01% |
25 |
|||
|
Hib
|
Hiberix |
GlaxoSmithKline |
0 |
0 |
|||
|
PedvaxHIB |
Merck |
0 |
0 |
||||
|
Hib+HepB
|
Comvax |
Merck |
0 |
0 |
|||
|
Hepatitis A
|
Havrix |
GlaxoSmithKline |
0 |
0 |
|||
|
Vaqta |
Merck |
0 |
0 |
||||
|
Hepatitis B
|
Engerix‐B |
GlaxoSmithKline |
0 |
0 |
|||
|
Recombivax HB |
Merck |
0 |
0 |
||||
|
Hep A+B
|
Twinrix |
GlaxoSmithKline |
0 |
0 |
|||
|
HPV
|
Cervarix |
GlaxoSmithKline |
0 |
0 |
|||
|
Gardasil |
Merck |
0 |
0 |
||||
|
Influenza 2012/13 Formula
|
Afluria |
single dose |
CSL Limited |
0 |
0 |
||
|
Agriflu |
|
Novartis |
0 |
0 |
|||
|
Fluarix |
|
GlaxoSmithKline |
0 |
0 |
|||
|
FluLaval |
|
GlaxoSmithKline |
.01% |
25 |
|||
|
FluMist |
|
MedImmune |
0 |
0 |
|||
|
Fluvirin |
prefilled syringe multi‐dose |
Novartis |
* |
* |
|||
|
Fluzone |
single dose |
sanofi pasteur |
0
.01% |
0 |
|||
|
multi‐dose |
25 |
||||||
| High Dose | 0 | 0 | |||||
| Intradermal | 0 | 0 | |||||
|
Japanese Encephalitis
|
Ixiaro |
commercial | military |
Intercell Bio |
0 |
0 |
||
|
JE‐Vax |
|
sanofi pasteur |
0.007% |
|
|||
|
Meningococcal
|
Menactra |
|
sanofi pasteur |
0 |
0 |
||
|
Menomune‐A/C/Y/W‐135 |
single dose multi‐dose |
sanofi pasteur |
0 .01% |
0 25 |
|||
|
Menveo |
|
Novartis |
0 |
0 |
|||
|
MMR
|
M‐M‐R II |
|
Merck |
0 |
0 |
||
|
MMR+Varicella
|
ProQuad |
|
Merck |
0 |
0 |
||
|
Polio
|
IPOL |
|
sanofi pasteur |
0 |
0 |
||
|
Pneumococcal
|
Pneumovax 23 |
|
Merck |
0 |
0 |
||
|
Prevnar |
|
Wyeth‐Ayerst |
0 |
0 |
|||
|
Prevnar 13 |
|
Wyeth‐Ayerst /o:p> |
0 |
0 |
|||
|
Rabies
|
Imovax |
|
sanofi pasteur |
0 |
0 |
||
|
RabAvert |
|
Chiron |
0 |
0 |
|||
|
Rotavirus
|
Rotarix |
|
GlaxoSmithKline |
0 |
0 |
||
|
RotaTeq |
|
Merck |
0 |
0 |
|||
|
Typhoid Fever
|
Typhim Vi |
|
sanofi pasteur |
0 |
0 |
||
|
Vivotif |
|
Berna Biotch |
0 |
0 |
|||
|
Varicella Zoster
|
Varivax |
|
Merck |
0 |
0 |
||
|
Zostavax |
|
Merck |
0 |
0 |
|||
|
Yellow Fever
|
YF‐VAX |
|
sanofi pasteur |
0 |
0 |
||
| * This product should be considered equivalent to thimerosal‐free products. This vaccine may contain trace amounts (<0.3 mcg) of mercury left after postproduction thimerosal removal; these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16). | |||||||
© 2012 Institute for Vaccine Safety